At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 63 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Dexmedetomidine 0.3 mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery
In Brief
A Phase 4 clinical trial evaluating Dexmedetomidine and Placebo for Strabismus and 2 related conditions. Completed, enrolled 63 participants across 1 site.
Detailed Summary
This study is trying to see if using precedex pre-operatively prevents emergence delirium in pediatric (ages 1-7) patients undergoing strabismus surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStrabismus, Delirium on Emergence, Pediatric Disorders
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedJul 2013
Primary CompletionMar 2014
Study CompletionMay 2016
TodayJul 2026
First PostedJul 17, 2013
Enrollment StartMar 1, 2012
Primary CompletionMar 1, 2014
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 13.0 years ago
Interventions
Dexmedetomidinedrug
intravenous dose of dexmedetomidine 0.3 mcg/kg over 5 minutes
Placeboother
intraoperative dose of intravenous placebo